Tag Archive: Yael Mossé

Feb 26 2018

John Maris, MD, Receives National Cancer Institute Outstanding Investigator Award

Long before he entered medical school, John M. Maris, MD, pediatric oncologist and the recent recipient of the National Cancer Institute’s Outstanding Investigator Award, became captivated by the mysteries of neuroblastoma. A cancer of the peripheral (not brain) nervous system, neuroblastoma accounts for 7 percent of all childhood cancers and 15 percent of all childhood cancer deaths.

Read the rest of this entry >>

Dec 30 2016

CHOP Research In the News: Rose Bowl Parade, Asthma, Cardiac Imaging, Pediatric Leukemia, Immune Response

CHOP Research In the NewsThe end of the year has come up fast, and so have important advances in pediatric research at Children’s Hospital of Philadelphia. This week’s In the News starts off with a celebration of two remarkable patients and their dedicated pediatric oncologist.

Read the rest of this entry >>

Oct 28 2016

CHOP Research In the News: Inspirational Patients, Pioneering Fetal Surgery, Trauma Recovery, ADHD Overdiagnosed in ASD, AAP Annual Meeting

CHOP Research In the NewsAlthough October is just ending, we’re already looking ahead to the New Year in this week’s installment of In the News.

Read the rest of this entry >>

Sep 6 2016

New Neuroblastoma Research Scholars Program Supports Young Scientist

EVAN_Foundation_cropYoung scientists may have passion and brilliant ideas, but unfortunately, they often do not add up to federal funding dollars. This is particularly problematic in pediatric cancer research, which receives just 4 percent of the National Cancer Institute’s $4.95 billion budget.

Read the rest of this entry >>

Mar 11 2016

CHOP Research In the News: Teen Crime, Tech Innovators, Tackling Concussions

CHOP Research In the NewsOur news highlights from this week cover some provocative topics in pediatric research, from serious teen violence in Philadelphia neighborhoods to head trauma injuries in student athletes across the country. Read on for details about the latest research developments and projects at The Children’s Hospital of Philadelphia.

Read the rest of this entry >>

Feb 2 2016

Scientists Discover a Better ALK Inhibitor to Treat Neuroblastoma

neuroblastomaPediatric cancer researchers at The Children’s Hospital of Philadelphia believe they have succeeded in their search for a powerful next-generation drug for neuroblastoma tumors with mutations in the anaplastic lymphoma kinase (ALK) gene associated with the cancer.

Read the rest of this entry >>